n | Before | After | Mean difference | p Value | |
---|---|---|---|---|---|
Values are mean (SD). p value was determined using the general linear model, with the values obtained before the intervention as covariate. | |||||
TAG, triacylglycerol; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; Apo B, apolipoprotein B. | |||||
FXIIa (ng/ml) | |||||
Walkers | 64 | 1.70 (0.6) | 1.55 (0.7) | −0.15 | |
Controls | 16 | 1.63 (0.7) | 2.14 (1.0) | +0.51 | 0.0001 |
TAG (mmol/l) | |||||
Female walkers | 43 | 1.16 (0.6) | 1.28 (0.8) | +0.12 | |
Female controls | 6 | 1.10 (0.3) | 1.13 (0.5) | +0.03 | 0.631 |
Male walkers | 22 | 1.52 (0.7) | 1.39 (1.0) | −0.13 | |
Male controls | 10 | 1.26 (0.3) | 1.22 (0.4) | −0.04 | 0.448 |
TC (mmol/l) | |||||
Walkers | 65 | 5.88 (1.1) | 5.78 (1.1) | −0.10 | |
Controls | 16 | 5.76 (0.9) | 5.94 (0.7) | +0.18 | 0.062 |
LDL-C (mmol/l) | |||||
Walkers | 62 | 3.56 (0.8) | 3.49 (0.8) | −0.07 | |
Controls | 16 | 3.53 (0.7) | 3.69 (0.7) | +0.16 | 0.060 |
HDL-C (mmol/l) | |||||
Female walkers | 43 | 1.65 (0.4) | 1.66 (0.3) | +0.01 | |
Female controls | 6 | 1.86 (0.5) | 1.91 (0.6) | +0.05 | 0.280 |
Male walkers | 22 | 1.27 (0.4) | 1.30 (0.3) | +0.03 | |
Male controls | 10 | 1.36 (0.3) | 1.35 (0.3) | −0.01 | 0.952 |
Apo B (g/l) | |||||
Walkers | 62 | 1.83 (0.6) | 1.80 (0.5) | −0.03 | |
Controls | 16 | 1.82 (0.4) | 1.90 (0.5) | +0.08 | 0.212 |